Home ETF List About

ETF Holdings Breakdown of ABBV

Stock NameAbbVie Inc
TickerABBV(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS00287Y1091
LEIFR5LCKFTG8054YNNRU85

ABBV institutional holdings

The adjusted close for ABBV on 2025-11-11 was 225.17

The following institutional investment holdings of ABBV have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-11-11 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 4,214,034USD 948,874,036 2.9% 225.17  
2025-11-11 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)) 4,214,034USD 948,874,036 2.9% 225.17  
2025-11-11 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 4,214,034USD 948,874,036 2.9% 225.17  
2025-11-11 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 2,752,849USD 619,859,009 2.9% 225.17  
2025-11-11 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 2,752,849USD 619,859,009 2.9% 225.17  
2025-11-11 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 2,752,849USD 619,859,009 2.9% 225.17  
2025-11-11 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 2,752,849USD 619,859,009 2.9% 225.17  
2025-11-11 IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist)) 619,639 -0.1%USD 139,524,114 2.8% 225.17  
2025-11-11 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 473,985 0.0%USD 106,727,202 4.2% 225.17  
2025-11-11 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 562,745USD 126,713,292 2.9% 225.17  
2025-11-11 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 562,745USD 126,713,292 2.9% 225.17  
2025-11-11 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 562,745USD 126,713,292 2.9% 225.17  
2025-11-11 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc)) 917,414 200.0%USD 206,574,110 197.1% 225.17  
2025-11-11 IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist)) 917,414 200.0%USD 206,574,110 197.1% 225.17  
2025-11-11 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 187,385 -0.4%USD 42,193,480 2.5% 225.17  
2025-11-11 IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc)) 269,992USD 52,431,305 2.5% 194.20 Incorrect share price reported. Should be 225.17 not 194.20. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-11-11 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 139,755USD 31,468,633 2.9% 225.17  
2025-11-07 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 140,637USD 30,822,005 0.1% 219.16 Incorrect share price reported. Should be 225.17 not 219.16. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-11-11 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 36,146 -0.1%USD 8,138,995 2.8% 225.17  
2025-11-11 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc)) 36,146 -0.1%USD 8,138,995 2.8% 225.17  
2025-11-11 IE00B8FHGS14 (iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc)) 67,927USD 15,295,123 2.9% 225.17  
2025-11-11 IE00BGPP8L80 (iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc)) 67,927USD 15,295,123 2.9% 225.17  
2025-11-11 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 118,021 -0.9%USD 22,919,179 1.6% 194.20 Incorrect share price reported. Should be 225.17 not 194.20. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-11-11 IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) 878,697USD 197,856,203 2.9% 225.17  
2025-11-11 IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF) 878,697USD 197,856,203 2.9% 225.17  
2025-11-11 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 78,547USD 17,686,428 2.9% 225.17  
2025-11-11 IE00B6SPMN59 (iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Acc)) 113,979 2.0%USD 25,664,651 4.8% 225.17  
2025-11-11 IE00BD93YH54 (iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist)) 113,979 2.0%USD 25,664,651 4.8% 225.17  
2025-11-11 IE00B57X3V84 (iShares Dow Jones Global Sustainability Screened UCITS ETF USD (Acc)) 152,426USD 34,321,762 2.9% 225.17  
2025-11-11 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 35,523USD 7,998,714 2.7% 225.17  
2025-11-11 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 79,044USD 17,798,337 2.9% 225.17  
2025-11-11 IE0002W8NB38 (iShares MSCI USA Swap UCITS ETF USD (Acc)) 133,380 160.3%USD 30,033,175 158.6% 225.17  
2025-11-11 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 125,698USD 28,303,419 2.9% 225.17  
2025-11-11 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 125,698USD 28,303,419 2.9% 225.17  
2025-11-11 IE00BMXC7V63 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc)) 59,359USD 13,365,866 2.9% 225.17  
2025-11-11 IE000G4PH2B1 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist) 59,359USD 13,365,866 2.9% 225.17  
2025-11-11 IE00BKM4H312 (iShares MSCI USA Dividend IQ UCITS) 84,333USD 18,989,262 2.9% 225.17  
2025-11-10 IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc)) 41,907USD 6,970,742 -0.2% 166.34 Incorrect share price reported. Should be 225.17 not 166.34. May be due to incorrect reporting of currency . Could be EUR or USD insteadIE00B3Y8X563 incorrectly reporting value of holding as USD actually is reported in GBP
2025-11-11 IE00BZ0PKT83 (iShares Edge MSCI World Multifactor UCITS ETF USD (Acc) GBP) 36,853USD 8,298,190 2.9% 225.17  
2025-11-11 IE00BYXPXK00 (iShares STOXX World Equity Multifactor UCITS ETF EUR Hedged (Acc)) 36,853USD 8,298,190 2.9% 225.17  
2025-11-11 IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc)) 35,359USD 7,961,786 2.9% 225.17  
2025-11-11 IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)) 10,308USD 2,321,052 2.9% 225.17  
2025-11-11 IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc)) 10,308USD 2,321,052 2.9% 225.17  
2025-11-11 IE00BKVL7331 (iShares Edge MSCI USA Minimum Volatility ESG UCITS ETF USD (Acc)) 609USD 137,129 2.9% 225.17  
2025-11-11 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 11,351USD 1,939,745 2.7% 170.89 Incorrect share price reported. Should be 225.17 not 170.89. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-11-11 IE000NITTFF2 (iShares Russell 1000 Growth UCITS ETF) 27,868USD 6,275,038 2.9% 225.17  
2025-11-11 IE00BZ0PKS76 (iShares STOXX USA Equity Multifactor UCITS ETF USD (Acc)) 5,081USD 1,144,089 2.9% 225.17  
2025-11-11 IE00BG13YZ23 (iShares Edge MSCI USA Multifactor UCITS ETF USD (Dist)) 5,081USD 1,144,089 2.9% 225.17  
2025-11-11 IE000KJPDY61 (iShares World Equity High Income UCITS ETF USD Inc) 4,081 91.1%USD 918,919 91.3% 225.17  
2025-11-11 IE000WHL2ZK1 (iShares U.S. Equity High Income UCITS ETF USD Inc) 1,235USD 278,085 2.9% 225.17  
2025-11-11 IE000D8XC064 (iShares World Equity Enhanced Active UCITS ETF USD (Acc)) 28,932USD 6,514,618 2.9% 225.17  
2025-11-11 IE0009VWHAE6 (iShares US Equity Enhanced Active UCITS ETF USD (Acc)) 41,210USD 9,279,256 2.9% 225.17  
2025-11-11 IE000YNE6S57 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Dist)) 284USD 63,948 2.9% 225.17  
2025-11-11 IE0001YGXFO5 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Acc)) 284USD 63,948 2.9% 225.17  
2025-11-11 IE0007O06KL9 (iShares Russell 2000 Swap UCITS ETF) 7,662 200.0%USD 1,725,253 197.1% 225.17  
2025-11-11 IE000YG82CF0 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Dist)) 262USD 58,995 2.9% 225.17  
2025-11-11 IE000MGAVJV3 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Acc)) 262USD 58,995 2.9% 225.17  
2025-11-11 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 779,134USD 175,437,603 2.9% 225.17  
2025-11-10 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 473,985USD 103,665,259 -0.2% 218.71 Incorrect share price reported. Should be 225.17 not 218.71. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-11-10 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 139,755 0.5%USD 30,565,816 0.4% 218.71 Incorrect share price reported. Should be 225.17 not 218.71. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-11-11 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 140,637USD 31,667,233 2.9% 225.17  
Total =34,092,141 USD 7,656,617,380
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with ABBV

AbbVie (NYSE:ABBV) Reaches New 12-Month High After Analyst Upgrade
AbbVie Inc. (NYSE:ABBV – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Thursday after Berenberg Bank upgraded the stock from a hold rating to a buy rating. Berenberg Bank now has a $270.00 price target on the stock, up from their previous price target of $170.00. AbbVie traded as […] - 2025-09-19 03:10:53
AbbVie (NYSE:ABBV) Upgraded by Berenberg Bank to Buy Rating
AbbVie (NYSE:ABBV – Get Free Report) was upgraded by investment analysts at Berenberg Bank from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, Marketbeat reports. The firm currently has a $270.00 price target on the stock, up from their previous price target of $170.00. Berenberg […] - 2025-09-19 02:24:45
Noteworthy Thursday Option Activity: ZS, CRM, ABBV
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Zscaler Inc (Symbol: ZS), where a total of 10,858 contracts have traded so far, representing approximately 1.1 million underlying shares. That amounts to about 58.1% of - 2025-09-18 16:21:04
Notable ETF Inflow Detected - ITOT, HD, ABBV, AMD
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P Total U.S. Stock Market ETF (Symbol: ITOT) where we have detected an approximate $179.9 million dollar inflow -- that's a 0.2% i - 2025-09-18 13:25:16
Guru Fundamental Report for ABBV
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks low volatility stocks that also have st - 2025-09-18 10:39:12
AbbVie (NYSE:ABBV) Trading Up 1.8% on Analyst Upgrade
AbbVie Inc. (NYSE:ABBV – Get Free Report) shares rose 1.8% on Wednesday after Berenberg Bank upgraded the stock from a hold rating to a buy rating. Berenberg Bank now has a $270.00 price target on the stock, up from their previous price target of $170.00. AbbVie traded as high as $221.55 and last traded at […] - 2025-09-18 03:08:42
ABBV Factor-Based Stock Analysis
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-17 10:34:46
AbbVie (NYSE:ABBV) Price Target Raised to $245.00
AbbVie (NYSE:ABBV – Get Free Report) had its target price boosted by equities researchers at Cantor Fitzgerald from $215.00 to $245.00 in a research note issued to investors on Monday, MarketBeat reports. The brokerage currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective points to a potential upside of 13.28% from the […] - 2025-09-17 02:56:46
ABBV Quantitative Stock Analysis
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-16 10:32:29
Validea Detailed Fundamental Analysis - ABBV
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-12 10:32:52
Company News for Sep 12, 2025
Companies in The News Are: TSLA, WBD, DOW, ABBV - 2025-09-12 10:18:00
The Best Stocks to Invest $50,000 In Right Now
Key PointsAbbVie is a Dividend King that's proven its resilience. - 2025-09-12 05:46:00
Notable Thursday Option Activity: ABBV, LRCX, UAL
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in AbbVie Inc (Symbol: ABBV), where a total volume of 26,476 contracts has been traded thus far today, a contract volume which is representative of approximately 2.6 - 2025-09-11 14:43:20
Noteworthy ETF Inflows: VONG, ABBV, HD, RCL
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Russell 1000 Growth ETF (Symbol: VONG) where we have detected an approximate $454.7 million dollar inflow -- that's a 1.4% increase week ove - 2025-09-10 11:51:17
ABBV Factor-Based Stock Analysis
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-10 10:34:13
Daily Dividend Report: VZ,ESS,AVGO,SACH,ABBV,NUE
The Board of Directors at Verizon Communications today declared a quarterly dividend of 69 cents per outstanding share, an increase of 1.25 cents per share from the previous quarter. The quarterly dividend is payable on November 3, 2025 to Verizon shareholders of record at the c - 2025-09-05 12:59:15
Guru Fundamental Report for ABBV
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-04 10:32:24
Validea Detailed Fundamental Analysis - ABBV
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-29 10:33:22
ABBV Factor-Based Stock Analysis
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-27 10:34:48
ABBV Quantitative Stock Analysis
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-26 10:34:00
Noteworthy ETF Inflows: SSO, ABBV, BAC, KO
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra S&P500 (Symbol: SSO) where we have detected an approximate $147.7 million dollar inflow -- that's a 2.1% increase week over week - 2025-08-25 13:36:49
Validea Detailed Fundamental Analysis - ABBV
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-22 10:34:21
ABBV Factor-Based Stock Analysis
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-20 10:33:59
Noteworthy ETF Outflows: ACWI, ABBV, BAC, KO
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $160.0 million dollar outflow -- that's a 0.7% decrease week over week (f - 2025-08-15 11:48:20
Validea Detailed Fundamental Analysis - ABBV
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-15 10:31:59
3 Dividend Stocks to Double Up On Right Now
Key PointsAbbVie is a Dividend King with an especially attractive valuation. - 2025-08-15 05:53:00
ABBV Quantitative Stock Analysis
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-12 10:33:16
Guru Fundamental Report for ABBV
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-07 10:34:43
AbbVie (NYSE:ABBV) Price Target Raised to $255.00
AbbVie (NYSE:ABBV – Free Report) had its target price boosted by Morgan Stanley from $250.00 to $255.00 in a research report released on Friday,Benzinga reports. Morgan Stanley currently has an overweight rating on the stock. A number of other analysts have also recently issued reports on the company. Cantor Fitzgerald assumed coverage on AbbVie in […] - 2025-08-04 04:57:06
AbbVie (NYSE:ABBV) Price Target Raised to $227.00
AbbVie (NYSE:ABBV – Free Report) had its target price boosted by Guggenheim from $216.00 to $227.00 in a report published on Friday morning,Benzinga reports. They currently have a buy rating on the stock. ABBV has been the subject of a number of other research reports. Citigroup boosted their target price on shares of AbbVie to […] - 2025-08-04 04:56:58

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.